End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.31 CNY | -1.40% |
|
+2.82% | -7.17% |
Jan. 29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
Oct. 25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Executive Committee: Changchun BCHT Biotechnology Co.
Manager | Positions heldSince | ||||
---|---|---|---|---|---|
Wei Kong 60 year |
| ||||
Zhao Feng Meng 61 year |
| ||||
Chang Lin Zhu 57 year |
| ||||
Zhe Zhang 50 year |
| ||||
Xue Lian Tong 35 year |
|
Composition of the Board of Directors: Changchun BCHT Biotechnology Co.
Director | CommitteesSince | ||||||
---|---|---|---|---|---|---|---|
Da Qiang Feng 59 year |
| ||||||
Jing Liu 63 year |
| ||||||
Da Yong Xu 61 year |
| ||||||
Xing Gong Zhu 58 year |
| ||||||
Bai Nian Fu 69 year |
| ||||||
Yun Tao Jiang 51 year |
| ||||||
Xiu Feng Li 56 year |
| ||||||
Ji Ma 60 year |
| ||||||
Yang Yang 40 year |
| ||||||
De Shen Zhang 61 year |
| ||||||
Chun Lai Jiang 52 year |
| ||||||
Wei Kong 60 year |
|
Former Officers and Directors: Changchun BCHT Biotechnology Co.
Insider | Positions held SinceUntil | |||
---|---|---|---|---|
| ||||
| ||||
| ||||
|
Age distribution of managers
Parity Men Women
Male | 15 |
---|---|
Female | 1 |
Of which Executive Committee
Male | 4 |
---|---|
Female | 1 |
Of which Directors
Male | 12 |
---|---|
Female | 0 |
Revisions
Departures of Key Persons
Chairman
2004-02-29 2021-07-08